VERACYTE, INC. Other Current Liabilities
VERACYTE, INC. (VCYT) had Other Current Liabilities of $0 as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-02-26
- 2025-12-31: Other Liabilities, Current $0.00.
- 2025-09-30: Other Liabilities, Current $0.00.
- 2025-06-30: Other Liabilities, Current $0.00.
- 2025-03-31: Other Liabilities, Current $7.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $7.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $19.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $53.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $72.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $89.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $101.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $106.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $119.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $127.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $186.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $180.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $198.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $218.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | $231.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $241.00K 10-Q · filed 2021-11-09 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |